BELX Bio-Pharmaceutical (Taiwan) Corporation
PrivateLast Round
Series B
Extension
Jan 22, 2021
Total Funding Raised
$1.58M
Company Overview
BELX Bio-Pharmaceutical (Taiwan) Corporation operates in Healthcare & Life Sciences and is based in Hsinchu. Its latest recorded funding round was a Grant round in November 2019.
BELX Bio-Pharmaceutical (Taiwan) Corporation is a biotechnology company that develops botanical new drugs for the treatment of tumors and chronic liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BELX Bio-Pharmaceutical (Taiwan) Corporation Comparables
Compare BELX Bio-Pharmaceutical (Taiwan) Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yiviva | 84% | |
| TaiRx, Inc. | 77% | |
| Phytohealth Corp | 69% |
For institutional investors. Book with your work email.
BELX Bio-Pharmaceutical (Taiwan) Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 22, 2021 | ||||
| Grant | Nov 1, 2019 | ||||
| Grant | Oct 1, 2018 | ||||
| Grant | Sep 1, 2018 | ||||
| Grant | Nov 27, 2017 | ||||
Series A | Jun 1, 2017 |
For institutional investors. Book with your work email.
BELX Bio-Pharmaceutical (Taiwan) Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwan ITRI New Venture Association | Seed |
| Taipei City Government | Grant |
| Industrial Technology Investment Corporation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2021
Completed a Series B Extension funding round.
- Nov 1, 2019
Received grant from the Ministry of Economic Affairs.
For institutional investors. Book with your work email.
BELX Bio-Pharmaceutical (Taiwan) Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BELX Bio-Pharmaceutical (Taiwan) Corporation's valuation, stock price, and market status.
Is BELX Bio-Pharmaceutical (Taiwan) Corporation a public or private company?
BELX Bio-Pharmaceutical (Taiwan) Corporation is a private company.
What is the current stock price of BELX Bio-Pharmaceutical (Taiwan) Corporation?
BELX Bio-Pharmaceutical (Taiwan) Corporation is a private company, so its shares have no public market price. Caplight tracks BELX Bio-Pharmaceutical (Taiwan) Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BELX Bio-Pharmaceutical (Taiwan) Corporation worth (valuation)?
Valuation information for BELX Bio-Pharmaceutical (Taiwan) Corporation is not publicly available.
Can I buy BELX Bio-Pharmaceutical (Taiwan) Corporation stock?
BELX Bio-Pharmaceutical (Taiwan) Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BELX Bio-Pharmaceutical (Taiwan) Corporation's last funding round?
BELX Bio-Pharmaceutical (Taiwan) Corporation's most recent funding round was Series B Extension on January 22, 2021.
Who are the main investors in BELX Bio-Pharmaceutical (Taiwan) Corporation?
Key investors in BELX Bio-Pharmaceutical (Taiwan) Corporation include Industrial Technology Investment Corporation.
Will BELX Bio-Pharmaceutical (Taiwan) Corporation IPO soon?
No public IPO plans have been announced for BELX Bio-Pharmaceutical (Taiwan) Corporation.
How can I track BELX Bio-Pharmaceutical (Taiwan) Corporation secondary market activity?
Caplight tracks bids, offers, and trades in BELX Bio-Pharmaceutical (Taiwan) Corporation's shares on secondary markets.